KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Non-Current Deferred Tax Liability (2020 - 2025)

Castle Biosciences (CSTL) has disclosed Non-Current Deferred Tax Liability for 6 consecutive years, with $2.3 million as the latest value for Q4 2025.

  • Quarterly Non-Current Deferred Tax Liability fell 90.39% to $2.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Dec 2025, down 90.39% year-over-year, with the annual reading at $2.3 million for FY2025, 90.39% down from the prior year.
  • Non-Current Deferred Tax Liability hit $2.3 million in Q4 2025 for Castle Biosciences, down from $3.2 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $24.3 million in Q4 2024 to a low of $206000.0 in Q4 2023.
  • Historically, Non-Current Deferred Tax Liability has averaged $2.7 million across 5 years, with a median of $624500.0 in 2021.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: soared 11690.29% in 2024 and later tumbled 90.39% in 2025.
  • Year by year, Non-Current Deferred Tax Liability stood at $635000.0 in 2021, then tumbled by 32.6% to $428000.0 in 2022, then crashed by 51.87% to $206000.0 in 2023, then skyrocketed by 11690.29% to $24.3 million in 2024, then crashed by 90.39% to $2.3 million in 2025.
  • Business Quant data shows Non-Current Deferred Tax Liability for CSTL at $2.3 million in Q4 2025, $3.2 million in Q3 2025, and $3.1 million in Q2 2025.